Quibim key facts
as of Oct 2026- Developer of a medical imaging platform designed for quantitative analysis and biomarker extraction.
- Quibim is valued at approximately $46.1M as of Oct 2026 (last reported valuation).
- It has raised $71.2M; the latest was Later Stage VC ($50.0M) in Jan 2025.
- Notable investors include Plug and Play Tech Center, European Commission, Partech, UI Investissement, KFund — 31 tracked in total.
- Status: Privately Held (backing).
Quibim's last reported valuation, Jul 2023. Nothing priced has surfaced since.
- ·The complete investor list: 31 names
- ·Watch Quibim: the Monday email on marks, rounds and moves
Quibim funding rounds
No funding rounds for Quibim are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Quibim
31+Quibim valuation
Quibim's last reported valuation was $46.1 million in Jul 2023. No priced round, secondary trade or fund mark has surfaced since.
Quibim investors
31 investors are on record for Quibim, including Plug and Play Tech Center, European Commission, Partech and UI Investissement. By type, the record holds 7 venture capital firms and 1 asset manager.
About Quibim
Developer of a medical imaging platform designed for quantitative analysis and biomarker extraction. The company's platform integrates deep learning algorithms and artificial intelligence with radiomics and multi-omics data processing to standardize imaging quality, automate feature extraction, and enhance disease detection, enabling healthcare providers and researchers to improve diagnostic accuracy and optimize patient monitoring through advanced imaging insights.
- Sector
- Healthcare
- HQ
- Valencia, Spain
- Founded
- 2012
- Employees
- 109
- Website
- quibim.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.